Expert Opinion on Orphan Drugs
| 短名 | Expert. Opin. Orphan. Drugs. |
| Journal Impact | 0.90 |
| 国际分区 | PHARMACOLOGY & PHARMACY(Q4) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 2167-8707 |
| h-index | 27 |
| 国内分区 | 医学(4区)医学药学(4区) |
| 涉及主题 | 医学生物内科学病理遗传学化学疾病生物化学重症监护医学免疫学生物信息学心理学外科精神科药理学基因 |
| 出版信息 | 出版商: Taylor and Francis Ltd.，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2013，原创研究文献占比: 50.00%，自引率:0.00%， Gold OA占比: 30.77% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Emerging therapies against <i>Naegleria fowleri</i>
2024-7-31
Management of pulmonary hypertension in infants
2024-7-27
The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022
2024-3-26
Current and emerging therapies for the treatment of leishmaniasis
2024-3-26
Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing
2024-2-2
Overview of genetic testing in Prader-Willi syndrome
2023-9-28
Real world data for rare diseases research: The beginner’s guide to registries
2023-8-1
Recommendations for the management of diarrhea with trofinetide use in Rett syndrome
2023-6-13
Making orphan drugs and services available and accessible for people who live with rare diseases: what has been done? a systematic scoping review
2022-12-2
Quality of life of patients with acromegaly: comparison of different therapeutic modalities
2022-12-2
Risdiplam as an orphan drug treatment of spinal muscular atrophy in adults and children (2 months or older)
2022-11-29
Targeting the IL-2 pathway for the treatment of mucosal melanoma
2022-10-16
Rare diseases: proposition of a list based on the Brazilian Health System
2022-10-16
Pricing and reimbursement policy for new orphan drugs in South Korea: focused on patient accessibility and budget impact
2022-10-8
Recommendations for overcoming challenges in the diagnosis of lysosomal acid lipase deficiency
2022-10-1
Molecular aspects of the altered Angiotensin II signaling in Gitelman’s syndrome
2022-5-3
Elucidating the pathogenesis of adenosine deaminase 2 deficiency: current status and unmet needs
2021-12-2
Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies
2021-12-2
Current medicines hold promise in the treatment of orphan infections due to brain-eating amoebae
2021-12-2
Adjuvant chemotherapy in patients with uterine carcinosarcoma: a review of clinical outcomes and considerations
2021-12-2
Pitolisant for the treatment of cataplexy in adults with narcolepsy
2021-12-2
Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
2021-10-3
Steroid alternatives for managing eosinophilic lung diseases
2021-10-3
An evaluation of onasemnogene abeparvovec for spinal muscular atrophy (<i>SMN1</i>)
2021-10-3
Efficacy of sirolimus for treatment of autoimmune lymphoproliferative syndrome: a systematic review of open label clinical studies
2021-8-27
Patient experience in a rare disease: application of the IEXPAC questionnaire in hereditary transthyretin-mediated amyloidosis
2021-6-3
European stakeholder perspectives on challenges to rare disease drug development – a qualitative study
2021-6-3
Current and innovative therapeutic strategies for the treatment of giant cell arteritis
2021-5-4
An evaluation of nifurtimox for Chagas disease in children
2021-5-4
Coenzyme Q<sub>10</sub> and the exclusive club of diseases that show a limited response to treatment
2021-5-4
Correlation between neurological features, nutritional status, and metabolic changes in patients with Ataxia-telangiectasia
2021-4-3
Advances in predicting patient survival in pulmonary sarcoidosis
2021-4-3
The national drug formulary listing process for orphan drugs in South Korea: narrative review focused on pricing and reimbursement pathways
2021-4-3
Old and novel prognostic biomarkers in primary biliary cholangitis
2021-4-3
Fusariosis: an update on therapeutic options for management
2021-3-4
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease
2021-3-4
Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency
2021-3-4
A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis
2021-3-4
Understanding the genetic pathology of Stargardt disease: a review of current findings and challenges
2021-2-1
Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients
2021-2-1
Clinical application of molecular biomarkers in Duchenne muscular dystrophy: challenges and perspectives
2021-2-1
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
2021-1-2
Recommendations and guidance on the diagnosis and management of Danon disease
2021-1-2
Phase three clinical trials in idiopathic pulmonary fibrosis
2021-1-2
Evolving treatments in high-risk neuroblastoma
2020-12-1
Managing respiratory complications in infants and newborns with congenital diaphragmatic hernia
2020-12-1
Assessing diagnosis and managing respiratory and cardiac complications of sarcoglycanopathy
2020-12-1
Gut microbial profiling as a therapeutic and diagnostic target for managing primary biliary cholangitis.
2020-12-1
Putative adjunct therapies to target mitochondrial dysfunction and oxidative stress in phenylketonuria, lysosomal storage disorders and peroxisomal disorders
2020-11-1
Inhibitory effect of Tunceli garlic (<i>Allium tuncelianum)</i> on <i>blastocystis</i> subtype 3 grown <i>in vitro</i>
2020-11-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远